Ramiah Investment Group

Position in ABBV — AbbVie Inc.

CIK 1566307 BROOKFIELD, WI

Position in ABBV

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$469,308

+$41,288 QoQ

Shares Held

1,865

-5.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.00%

of 13F equity value

Holder Rank

#3,229

of 4,153 holders

Holding Since

Jun 2020

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ramiah Investment Group holds $2,594,267 across 6 Drug Manufacturers - General names. ABBV ranks #3 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	4,246	$545,611
2	AMGN	Amgen Inc	1,454	$526,522
3	ABBV	AbbVie Inc. This page	1,865	$469,308
4	BIIB	Biogen Inc.	2,085	$450,485
5	GILD	Gilead Sciences, Inc.	3,004	$379,525
6	BMY	Bristol Myers Squibb Co	3,867	$222,816

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$469,308	1,865	-5.2%	Shares	Sole	2026-07-16
2026-03-31	$428,020	1,968	-3.1%	Shares	Sole	2026-05-29
2025-12-31	$464,063	2,031	-13.6%	Shares	Sole	2026-05-29
2025-09-30	$544,350	2,351	+2.9%	Shares	Sole	2026-05-29
2025-06-30	$423,956	2,284	-12.7%	Shares	Sole	2026-05-29
2020-06-30	$256,937	2,617	—	Shares	Sole	2026-05-29
No filing history on record for this holder in this stock.